Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Five inspiration points in Westport’s new Freedom design showroom (Photos)
Carol Espinosa bears a striking grin as she bounds up the steps to the rejuvenation area at Freedom Interiors. Palpable excitement beams through her voice. “This is possibly my favorite part of the showroom,” she says, pointing out the lush green carpeting, comfy seating and 360-degree view of the renovated space at 4000 Washington St.…
Brazil to KC: Carol Espinosa showcases path to creativity, opportunity
She arrived in the United States with just two suitcases and her own creativity, but today Carol Espinosa fills a 7,000-square-foot Westport storefront with enough modern workplace designs to unpack for weeks, she said. “This company was built from nothing,” said Espinosa, founder of Freedom Interiors. “It started with no customers, no product offerings —…
American buying habits push Swappa to $70M in 2017 hand-me-down tech sales
Grown from a one-person, side-hustle project to a team of more than 30 people, Kansas City-based Swappa is swelling. The user-to-user marketplace for buying and selling used technology enjoyed its best year to date in 2017. The platform sold more than $70 million in hand-me-down electronics in 2017 — up about 17 percent from 2016, said…
BKS Artisan Ales takes measured approach with nano-brewery concept
It takes only about an hour for BKS Artisan Ales to sell out of its packaged bottles and cans each Saturday afternoon, Brian Rooney said. “We thought it would be great if maybe 40 people came in and maybe each of those 40 took a beer home,” said Rooney, a craft brewer who owns and…